About The Author

Galit Lahav received her PhD in 2001 from the Department of Biology at the Technion, Israel Institute of Technology. Between the years 2001-2003, she completed her postdoctoral fellowship at the Weizmann Institute of Science. She then spent an additional year at Harvard’s Bauer Center for Genomics Research and in the fall of 2004 she joined the Department of Systems Biology. She has been recognized for her excellence in both teaching and research through several awards and honors including the Vilcek prize for Creative Promise in Biomedical Science and an Excellence in Mentoring award from HMS.

Dr. Lahav is a dedicated mentor to new faculty at Harvard and has been organizing a series of workshops and courses on leadership and management skills for Harvard junior faculty. She is also highly committed to the advancement of women in science and is always happy to share her experience balancing the challenges associated with being a mother in academia .

Keeping Up With Moving Targets: How Do Cancer Cells Switch In And Out Of Therapy-Resistant States?

Tumors result from the expansion of cells that bypass the regulatory mechanisms that otherwise control the birth, death, and elimination of cells within healthy tissues. The overarching goal of cancer therapy is to halt such proliferation and eliminate cancer cells while sparing their non-cancerous counterparts. Although many treatments are successful in eradicating a large fraction